VerTan Technologies is a holding nanotechnology company focused on developing next-generation AI-driven therapeutics and consumer products, NobleFusion™ Nanoparticles.
Nanotechnology and Artificial Intelligence are seamlessly integrating into our daily lives, revolutionizing various industries with their immense potential. At VerTan Technologies, we harness the power of both these groundbreaking technologies to create unique, cutting-edge solutions.
Our Patented Nanotechnology Platform offers a vast array of bio-active nano-formulations, NobleFusion™, ranging from anti-cancer to anti-microbial. To navigate this expansive range of possibilities, we employ EurekaAI®, which helps us choose the right formulation for the right application, saving time, reducing costs, and focusing on the most promising targets.
Properly Designed Nanoparticles can be utilized across numerous fields, addressing a wide variety of challenges. Based on our data, our platform is particularly well-suited for applications in medicine, cosmetics, agriculture, and veterinary science. We have already identified some of the most promising directions and are starting our journey there.
With These Powerful Tools at our disposal, the future opportunities are boundless. We are committed to leveraging this technology to explore and develop innovative solutions that will transform industries and improve lives.
What are Nanoparticles?
Nanoparticles are unique tiny objects, typically ranging from 1 to 100 nanometers in size. For comparison, they are smaller than living cells and viruses but larger than individual atoms and molecules. This unique size allows them to interact effectively with cells while being capable of carrying hundreds of active ingredient units for targeted delivery. To put this in perspective, one nanometer is one-billionth of a meter, making nanoparticles invisible to the naked eye yet incredibly powerful in their applications. This size enables them to traverse biological barriers and deliver therapeutic agents precisely where needed, offering significant potential across various scientific and medical fields.
Biological Barrier Penetration
One of the most remarkable features of nanoparticles is their ability to penetrate biological barriers. Due to their small size and biocompatibility, nanoparticles can traverse cell membranes, skin layers, and even the blood-brain barrier. This makes them invaluable in medical applications, where traditional drug delivery methods fall short.
Drug Delivery
Nanoparticles can be engineered to deliver drugs directly to specific sites in the body or even act as drugs themselves. This targeted delivery ensures that medications are concentrated where they are needed most, reducing side effects and increasing efficacy. For instance, in cancer treatment, nanoparticles can be designed to target tumor cells specifically, sparing healthy cells and reducing the collateral damage often seen with conventional chemotherapy.
Versatile Applications
The versatility of nanoparticles allows them to be designed for a wide range of applications across different fields:
Cancer: Nanoparticles’ enhanced permeability and retention effect enable them to target cancer cells more effectively than traditional treatments. They can carry chemotherapeutic agents directly to tumors, minimizing side effects and improving patient outcomes.
Cosmetics: In the cosmetic industry, nanoparticles are revolutionizing skincare by delivering active ingredients deep into the skin layers. This ensures more effective hydration, anti-aging benefits, and treatment of skin conditions.
Antibacterial/Veterinary: Certain nanoparticles possess strong antimicrobial properties, making them effective against antibiotic-resistant bacteria. This is crucial not only for human medicine but also for veterinary applications, where bacterial infections can have severe implications.
Agriculture: Nanoparticles are being used to deliver nutrients and pesticides more efficiently in agriculture. This not only increases crop yields but also reduces the environmental impact by minimizing the amount of chemicals needed.
No doubt, nanoparticles are the future of technology and medicine.
ABOUT US
Founded in January 2024 following the approval of a key patent, VerTan Technologies builds on pioneering research in nanoparticle technology. Originally focused on antimicrobial properties of silver nanoparticles, our co-founders expanded the technology’s applications to include cancer therapies and cosmetics. They developed a method to combine different noble metals into single nanoparticles, achieving enhanced effects with biologically active coatings.
To further harness the potential of these nanoparticle formulations, we developed EurekaAI, an advanced predictive platform designed to identify new applications and optimal formulations from our patented pool, significantly reducing R&D costs and time.
EurekaAI has already predicted several potent formulations for anti-aging and anti-inflammatory cosmetics, which will be marketed in partnership with a company specializing in laser cosmetic devices, providing early-stage revenue. Future development stages will target the agriculture and veterinary sectors, as identified by EurekaAI.
OUR MISSION
Our mission is to combine the enormous analytical and predictive powers of AI with the capabilities of nanotechnology. Gold, silver, and platinum nanoparticles are well-known for their antimicrobial, anti-aging, and anti-inflammatory properties, and their beneficial action on certain cell types. Gold nanoparticles, for example, are widely used for delivering therapies due to their biocompatibility. However, various biologics used in cosmetics and medicine often lack effective penetration abilities. Miramistin, a powerful yet low-toxic antibacterial, antifungal, and antiviral agent, is no longer patentable, which limits its market potential. VerTan’s proprietary approach enables exploration of applications in multiple fields:
We have demonstrated that combining platinum with other metals and cargo is toxic to cancer cells. The unique ability of cancer cells to accumulate nanoparticles further enhances their therapeutic action, including optical and thermal effects, offering a promising approach to cancer treatment.
Our nanoparticles provide the well-known benefits of noble metals for skin anti-aging, anti-inflammation, and anti-acne treatments. Their tunable sizes allow for efficient penetration of cosmetic products to the desired depth, improving effectiveness and user satisfaction.
Building on the success of our silver colloid products (Argumistin™), which have proven highly effective against a wide range of pathogens in domestic and livestock animals, our improved formulations will require smaller dosages, offer higher efficiency, and provide additional benefits not previously expected.
Our previous platform resulted in a highly efficacious product for increasing crop yields (Zerebra Agro™), with an average yield increase of 40% after treatment. The new platform offers similar applications with higher expected benefits due to synergistic metal combinations and added cargo. Our non-toxic and sustainable formulations are suitable for use in organic farming, providing a powerful tool to enhance crop yield and health without compromising safety and sustainability. After application, the noble metals revert to their less reactive, elemental states through natural processes, maintaining the natural balance within the soil ecosystem and mitigating long-term environmental impact. At VerTan Technologies, our mission is to harness the power of nanotechnology to develop smart, efficient, and highly targeted solutions. We strive to create nanoparticles that act as nano-robots, capable of precise and intelligent actions to improve health outcomes, enhance product performance, and promote sustainability.
OUR VISION
VerTan Technologies envisions a future where AI and nanotechnology transform industries by providing smart, high-performance solutions. We aim to lead the way in nanotechnology innovation, continuously pushing the boundaries of what is possible to create a better, more sustainable world.
OUR TEAM
Founded by a team of leading scientists and innovators, our team possesses a broad range of expertise suited for our large-scale platform needs.
Co-Founder, CTO, Patent Holder
Dr. Regina Vertelova, MD, PhD
Dr. Vertelova holds an MD and a PhD in Economics. She began her career as a clinical histologist before transitioning to biotechnology, where she studied stem cell therapies and cancer stem cells. As a director at StemCutis, a cosmetic company developing biologics for skin care, she designed pre-clinical studies and identified potential opportunities for the company. She has worked in cGMP quality control environments, developing potency assays, and has authored numerous publications and abstracts.
Founder, CEO
Dr. Gregory Vertelov, PhD
Dr. Vertelov holds a PhD in Medicinal Chemistry. His broad expertise ranges from organic and medicinal chemistry to regulatory and quality control in biotechnology. He has authored several inventions during his academic research. His invention of synergistic silver colloids with Miramistin sparked the field of combining different nanoparticles with antibacterial stabilizers. The related paper has been cited more than 145 times by other scientists. He has worked with cancer primary and stem cells and authored an educational book on cancer for colleges.
software architect
Umed Zokirov
Experienced software architect and a team leader. Designed and built applications, platforms and services targeting consumers and software developers alike.
Extensive expertise in architecting, implementing and operating large-scale distributed systems serving millions of users. Currently helping Intuit to effectively collaborate with established companies as well as startups in financial, compliance and artificial intelligence fields.
OUR SCIENTIFIC ADVISERS
Dr. Alexander Groisman
UCSD Professor with a PhD from MIT. Dr. Groisman is a distinguished physicist interested in complex physical phenomena at the microscale and nanoscale levels. His research explores fundamental questions related to the behavior of soft materials and biological systems, with applications ranging from biomedical engineering to environmental science.
Dr. Jeffrey Schwartz
Princeton University Professor with a PhD from Stanford University. Dr. Schwartz is a renowned chemist whose research focuses on the design and synthesis of novel materials with applications in renewable energy, biomedicine, and nanotechnology. He is known for his pioneering work in materials science, particularly in the development and characterization of advanced nanomaterials.
OUR TECHNOLOGY:
VERTAN TECHNOLOGIES: Building AI on the First Ever Patented Multi-Metal Nanoparticles
VerTan Technologies is developing a new AI platform, EurekaAI®, which will be trained to navigate the extensive and almost unlimited field of multi noble metal nanoparticles covered by our patent. This nanoparticle platform forms the foundation of our product development pipeline, which includes applications in cancer treatment, cosmetics, veterinary medicine, and more.
EurekaAI® will facilitate the candidate search process and significantly reduce the time needed for product selection, development, and formulation. Additionally, it will help identify the optimal applications for our technologies. VerTan’s nanoparticle technology is designed to combine noble metals in a proprietary way to enhance stability, biocompatibility, and activity. This platform can be used to precisely deliver a wide range of biologics and other cargo for targeted applications, improving efficacy and reducing side effects.
Product Formulation
Noble Metals:
Proprietarily combined to produce NobleFusion™ nanoparticles.
Coating:
Coated with Miramistin for stability, biocompatibility, and synergistic enhancement of activity.
Targeting and Cargo Loading:
Biologics and other cargo are loaded according to the desired application.
VerTan’s production approach promises a simplified design to lower costs and increase practicality, while delivering cutting-edge products.
AI based optimization
Leverage AI Technology:
Utilize existing AI frameworks or build an AI tailored to our specific needs.
Collecting Training Data:
Our Unique Datasets and all available information regarding noble metals, their structures, applications, and properties are used to train the AI engine.
AI Predictions:
Use the AI to predict optimal sub-platforms for desired applications based on the compiled data.
At VerTan Technologies, we believe in the predictive power of AI to save significant funds in future product development. Additionally, our ability to create custom products offers potential for additional revenue through licensing.
Expected Applications
Anti-Cancer
Promising Anti-Cancer Activity:
Our in vitro data indicated promising anti-glioblastoma and ovarian cancer activity of platinum-based NobleFusion™ nanoparticles.
Safer Alternatives:
Our technology rethinks highly toxic but effective anticancer drugs containing platinum (Pt) and ruthenium (Ru), providing safer, biocompatible, and efficacious synergistic alternatives.
Targeted Delivery:
Coupling cargo and biologics provides targeted delivery and an additional anti-cancer effect, further enhancing their action.
Miramistin Coating:
Miramistin not only lowers overall toxicity and potentiates the action but also synergistically provides antimicrobial action, which is often needed in cancer patients.
Our primary targets will be glioblastoma and ovarian cancer. However, we anticipate a much broader anticancer spectrum based on the similarity of anti-cancer mechanisms and the customization potential of our sub-platforms.
Anti-microbial: Human products, Veterinary and Agriculture
In Vitro Efficacy:
Our in vitro data explicitly showed that some of our NobleFusion™ sub-platforms have profound anti-microbial potential, even against antibiotic-resistant strains.
Resistance Prevention:
Due to the multi-targeted mode of action and historical data, we anticipate little or no resistance being acquired by microorganisms to our products.
Proven Success:
Our first-generation silver-Miramistin nanoparticles were efficacious as veterinary and agricultural products, with excellent market adoption and efficacy. This next generation of products will enhance and broaden their activity.
Key Features:
Low toxicity, sustainability in production, and formulation are expected to be attractive features of our products.
It is now known that some noble metal nanoparticles can destroy certain viruses, such as SARS-CoV-2. Additionally, Miramistin has demonstrated anti-viral properties. The combination of these components in one entity is believed to generate a powerful human anti-viral drug. Considering the lack of effective antiviral drugs on the market and the growing demand for them, we believe this could become another potential application of one of our sub-platforms.
Cosmetics
Enhanced Penetration:
The use of NobleFusion™ nanoparticles allows for enhanced penetration and delivery of active ingredients into the deeper layers of the skin, improving efficacy and visible results. The penetration depth can be manipulated by adjusting the size of the nanoparticles.
Noble Metals:
Noble metals have been known for centuries for their beneficial effects in cosmetics. Many existing products contain nanoparticles, but combining two or more noble metals in one nanoparticle for enhanced synergistic action is a unique feature of VerTan Technologies.
Anti-Aging and Anti-Inflammatory Effects:
We believe significant anti-aging and anti-inflammatory effects can be achieved by using selected noble metals, particularly through their combinations.
Miramistin Benefits:
The inclusion of Miramistin provides additional benefits such as antimicrobial protection, ensuring the formulations are safe and effective.
- Given the versatility of our technology, we anticipate broader applications in the cosmetic industry, including treatments for various skin conditions and enhancements in overall skin health. The growing demand for anti-aging and anti-inflammatory cosmetic products underscores the potential of our technology to meet market needs and drive innovation in the industry.